Glenmark Therapeutics Launches Adapalene Gel USP 0.1% in New Pump Packs in US
MM Desk
7 October, 2026
Glenmark Therapeutics Inc, USA, has launched Adapalene Gel USP, 0.1% (OTC) in new pump packs
Glenmark Therapeutics Inc, USA, has launched Adapalene Gel USP, 0.1% (OTC) in new pump packs
Glenmark Pharmaceuticals Ltd has received the Establishment Inspection Report (EIR) from the US Food and
Glenmark Specialty SA a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd (BSE: 532296 | NSE:
Glenmark Pharmaceuticals Limited has received approval from the US Food and Drug Administration (US FDA)
Glenmark Pharmaceuticals Inc, USA has launched Calcium Gluconate Injection USP in three presentations for the
Glenmark Pharmaceuticals Inc, USA, has announced the launch of Sugammadex Injection in 200 mg/2 mL
Glenmark Specialty SA has received approval from the US Food and Drug Administration (FDA) for
Glenmark Pharmaceuticals Inc, USA has announced the commercial launch of Methylene Blue Injection USP, 50
Glenmark Pharmaceuticals Inc USA has announced the launch of Lacosamide Injection USP, 200 mg/20 mL
Glenmark Pharmaceuticals has announced the launch of Vancomycin Hydrochloride for Injection USP in 500 mg/vial